var data={"title":"Post-endoscopic retrograde cholangiopancreatography (ERCP) bleeding","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Post-endoscopic retrograde cholangiopancreatography (ERCP) bleeding</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/contributors\" class=\"contributor contributor_credentials\">Andrea Tringali, MD, PhD</a></dd><dd><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/contributors\" class=\"contributor contributor_credentials\">Silvano Loperfido, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/contributors\" class=\"contributor contributor_credentials\">Francesco Ferrara, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/contributors\" class=\"contributor contributor_credentials\">Guido Costamagna, MD, FACG</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/contributors\" class=\"contributor contributor_credentials\">Douglas A Howell, MD, FASGE, FACG</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/contributors\" class=\"contributor contributor_credentials\">Kristen M Robson, MD, MBA, FACG</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jul 11, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Bleeding was the most feared complication when therapeutic biliary endoscopy was first introduced [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/1\" class=\"abstract_t\">1</a>]. Because of advances in equipment and experience, it has become a relatively uncommon complication of endoscopic retrograde cholangiopancreatography (ERCP), and it is mostly observed after sphincterotomy. Clinically significant bleeding is uncommon with diagnostic ERCP, apart from sporadic Mallory-Weiss tears and from minor submucosal hemorrhages observed following manipulation of the papilla, particularly in patients with ampullary tumors, a bleeding diathesis, or anatomical variants such as Billroth II gastrectomy [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/2-4\" class=\"abstract_t\">2-4</a>]. Exceptions are case reports in which serious bleeding occurs from injury to the spleen, liver, or abdominal vessels. (See <a href=\"topic.htm?path=rare-complications-of-endoscopic-retrograde-cholangiopancreatography-ercp\" class=\"medical medical_review\">&quot;Rare complications of endoscopic retrograde cholangiopancreatography (ERCP)&quot;</a>.)</p><p>This topic review will focus on the risk factors and treatment of bleeding following ERCP with endoscopic sphincterotomy. An overview of the complications of ERCP and detailed discussions of individual complications are presented separately. (See <a href=\"topic.htm?path=endoscopic-retrograde-cholangiopancreatography-indications-patient-preparation-and-complications\" class=\"medical medical_review\">&quot;Endoscopic retrograde cholangiopancreatography: Indications, patient preparation, and complications&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">ASSESSING SEVERITY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Post-ERCP bleeding can be defined as clinically significant or not clinically significant [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/5\" class=\"abstract_t\">5</a>] and can be graded as mild, moderate, or severe based upon a consensus definition [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/6\" class=\"abstract_t\">6</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mild &ndash; clinical evidence of bleeding (ie, not just endoscopic), hemoglobin drop &lt;3 <span class=\"nowrap\">g/dL,</span> and no need for transfusion</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Moderate &ndash; need for transfusion (4 units or less), and no angiographic intervention or surgery</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Severe &ndash; transfusion of 5 units or more, or intervention (angiographic or surgical)</p><p/><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">TIMING</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Approximately one-half of bleeding complications occur immediately after sphincterotomy; a delay of 24 hours up to several days is observed in other patients [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/7-12\" class=\"abstract_t\">7-12</a>]. The possibility of late bleeding raises some concern in the context of outpatient therapeutic ERCP [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/9,13,14\" class=\"abstract_t\">9,13,14</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">INCIDENCE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In multiple prospective studies, the reported rate of bleeding related to ERCP is approximately 1 to 2 percent [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/1,2,7,15-19\" class=\"abstract_t\">1,2,7,15-19</a>]. In a review of 21 studies of over 16,000 patients undergoing ERCP, there were a total of 226 bleeding episodes (1.3 percent), with eight deaths (0.05 percent) [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/20\" class=\"abstract_t\">20</a>]. Bleeding was severe in 66 of the 226 episodes (29 percent). </p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">RISK FACTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The risk factors for bleeding as a result of ERCP that have been identified in one or more studies can be categorized as follows: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Patient-related factors</strong>:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Coagulopathy [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/7,21-23\" class=\"abstract_t\">7,21-23</a>]</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Anticoagulation within three days after procedure [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/7\" class=\"abstract_t\">7</a>] </p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Antiplatelet drugs before and after high risk procedures</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Cirrhosis (Child class C (<a href=\"image.htm?imageKey=GAST%2F78401\" class=\"graphic graphic_table graphicRef78401 \">table 1</a>)) [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/24\" class=\"abstract_t\">24</a>]</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Renal failure [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/23\" class=\"abstract_t\">23</a>]</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Hemodialysis [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/21,25\" class=\"abstract_t\">21,25</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Technique-related factors:</strong> </p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Rapid cutting (ie, &quot;zipper&quot; cut) [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/22\" class=\"abstract_t\">22</a>]</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Sphincterotomy length [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/7,9,26\" class=\"abstract_t\">7,9,26</a>] </p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Needle-knife sphincterotomy [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/22\" class=\"abstract_t\">22</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Operator-related factor</strong>: low case volume of the endoscopist [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/2,7\" class=\"abstract_t\">2,7</a>]</p><p/><p>Other potential risk factors include extension of a previous sphincterotomy [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/27\" class=\"abstract_t\">27</a>], peripapillary diverticulum [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/27\" class=\"abstract_t\">27</a>], Billroth II gastrectomy [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/9\" class=\"abstract_t\">9</a>], stenosis of the orifice of the papilla of Vater [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/15\" class=\"abstract_t\">15</a>], ampullary cancer [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/22\" class=\"abstract_t\">22</a>], stone impaction [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/22\" class=\"abstract_t\">22</a>], and cholangitis [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/7\" class=\"abstract_t\">7</a>]. (See <a href=\"topic.htm?path=endoscopic-retrograde-cholangiopancreatography-ercp-after-billroth-ii-reconstruction\" class=\"medical medical_review\">&quot;Endoscopic retrograde cholangiopancreatography (ERCP) after Billroth II reconstruction&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">PREVENTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The risk of bleeding can be minimized by identifying patients at risk, taking measures to correct coagulopathy, and using careful technique.</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Prothrombin time and platelet count</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Our approach is to obtain a complete blood count and prothrombin <span class=\"nowrap\">time/international</span> normalized ratio (INR) before ERCP, particularly if an intervention (such as sphincterotomy) is anticipated [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/7,28\" class=\"abstract_t\">7,28</a>]. A platelet count exceeding 50,000 to <span class=\"nowrap\">80,000/microL</span> and an INR &lt;1.2 are generally found to be safe [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/7,29-32\" class=\"abstract_t\">7,29-32</a>]. (See <a href=\"topic.htm?path=endoscopic-retrograde-cholangiopancreatography-indications-patient-preparation-and-complications#H70259351\" class=\"medical medical_review\">&quot;Endoscopic retrograde cholangiopancreatography: Indications, patient preparation, and complications&quot;, section on 'Preprocedure testing'</a>.)</p><p>The guidelines from the American Society for Gastrointestinal Endoscopy recommend coagulation studies only in selected patients with active bleeding, a known or suspected bleeding disorder (including a history of abnormal bleeding), an increased risk of bleeding due to medication use (eg, use of anticoagulants, prolonged antibiotic use), prolonged biliary obstruction, malnutrition, or other conditions associated with acquired coagulopathies [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/33\" class=\"abstract_t\">33</a>]. However, some endoscopists restrict pre-ERCP coagulation screening to patients with an elevated bilirubin, who are receiving an anticoagulant, or who have a history of a bleeding diathesis [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/34\" class=\"abstract_t\">34</a>]. </p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Identifying patients at risk</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>As a general rule, sphincterotomy is contraindicated in patients with severe coagulation disorders, such as patients with advanced liver disease, in patients with hematologic diseases, and in patients with disorders of hemostasis, such as hemophilia and von Willebrand disease. </p><p>Postprocedure observation should be extended in patients with portal hypertension or cirrhosis. </p><p>Patients with known platelet dysfunction (such as patients on hemodialysis) should receive appropriate preventive measures, which may include infusion of <a href=\"topic.htm?path=desmopressin-drug-information\" class=\"drug drug_general\">desmopressin</a> (DDAVP). (See <a href=\"topic.htm?path=platelet-dysfunction-in-uremia\" class=\"medical medical_review\">&quot;Platelet dysfunction in uremia&quot;</a>.)</p><p>In addition to the risk factors discussed above, caution is advisable in patients with a papillary tumor. This condition is probably a risk factor for bleeding based upon pathophysiologic and technical considerations and clinical experience [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/35\" class=\"abstract_t\">35</a>]. Bleeding rates after papillectomy (also called ampullectomy) range from 2 to 13 percent. (See <a href=\"topic.htm?path=ampullary-adenomas-management\" class=\"medical medical_review\">&quot;Ampullary adenomas: Management&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Optimizing coagulation abnormalities</span></p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h3\">Correction of clotting defects</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Controversy remains regarding the appropriate use of platelet and coagulation factor transfusions in high-risk patients. Correction of clotting defects with fresh-frozen plasma, <a href=\"topic.htm?path=vitamin-k-phytonadione-drug-information\" class=\"drug drug_general\">vitamin K</a>, or platelet transfusion has permitted successful endoscopic sphincterotomy in patients with cirrhosis [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/9,29\" class=\"abstract_t\">9,29</a>]. Consultation with an expert in coagulation disorders is recommended before performing endoscopic procedures in patients with disorders of hemostasis. (See <a href=\"topic.htm?path=endoscopic-procedures-in-patients-with-disorders-of-hemostasis\" class=\"medical medical_review\">&quot;Endoscopic procedures in patients with disorders of hemostasis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h3\">Antiplatelet drugs</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=aspirin-drug-information\" class=\"drug drug_general\">Aspirin</a>, other nonsteroidal anti-inflammatory drugs (NSAIDs) and antiplatelet drugs (ie, <a href=\"topic.htm?path=ticlopidine-united-states-not-available-drug-information\" class=\"drug drug_general\">ticlopidine</a>, <a href=\"topic.htm?path=clopidogrel-drug-information\" class=\"drug drug_general\">clopidogrel</a>, and <a href=\"topic.htm?path=prasugrel-drug-information\" class=\"drug drug_general\">prasugrel</a>) have the potential to increase the risk of bleeding [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/36-39\" class=\"abstract_t\">36-39</a>]. The management of antiplatelet therapy can be individualized depending on the thrombotic risk of the patient and the bleeding risk related to the endoscopic procedure. Several professional societies recommend discontinuing clopidogrel and prasugrel before endoscopic sphincterotomy, while aspirin can be continued [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/4,40,41\" class=\"abstract_t\">4,40,41</a>]. However, for patients undergoing high-risk procedures (ie, endoscopic ampullectomy), some clinicians elect to also stop aspirin and NSAIDs five to seven days prior to the procedure. Further recommendations regarding the management of antiplatelet agents in patients undergoing endoscopic procedures are discussed separately. (See <a href=\"topic.htm?path=management-of-antiplatelet-agents-in-patients-undergoing-endoscopic-procedures\" class=\"medical medical_review\">&quot;Management of antiplatelet agents in patients undergoing endoscopic procedures&quot;</a>.)</p><p>In a retrospective study of 132 patients taking antiplatelet drugs (<a href=\"topic.htm?path=aspirin-drug-information\" class=\"drug drug_general\">aspirin</a> users comprised the largest proportion) who were undergoing endoscopic sphincterotomy, 49 patients continued antiplatelet therapy, while 83 patients stopped antiplatelet therapy &lt;7 days prior to procedure [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/42\" class=\"abstract_t\">42</a>]. Post-endoscopic sphincterotomy delayed bleeding was more frequent in patients who continued antiplatelet therapy compared with patients who discontinued antiplatelet agents (14 versus 2 percent).</p><p>In a case-control study of over 61,000 patients who underwent ERCP with either sphincterotomy or papillary balloon dilation for choledocholithiasis, the rate of severe bleeding was increased in those receiving anticoagulants compared with non-users for both sphincterotomy (1.6 versus 0.8 percent) and balloon dilation (3.0 versus 0.7 percent) [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/43\" class=\"abstract_t\">43</a>]. </p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h3\">Anticoagulants</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In patients receiving <a href=\"topic.htm?path=warfarin-drug-information\" class=\"drug drug_general\">warfarin</a> or heparin, the decision to reverse anticoagulation and the extent of anticoagulation reversal should be individualized based upon the relative risk of the procedure and the underlying condition. </p><p>Our approach is consistent with guidelines from several societies:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For high risk endoscopic procedures in patients at low risk of thrombotic risk, society guidelines recommend discontinuing <a href=\"topic.htm?path=warfarin-drug-information\" class=\"drug drug_general\">warfarin</a> five days before the procedure and checking INR prior to the procedure (goal INR &lt;1.5) [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/41\" class=\"abstract_t\">41</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For high risk endoscopic procedures in patients at high risk of thrombosis, <a href=\"topic.htm?path=warfarin-drug-information\" class=\"drug drug_general\">warfarin</a> should be temporarily discontinued and substituted with low molecular weight heparin. The approach to bridge therapy and resumption of oral anticoagulants is discussed separately. (See <a href=\"topic.htm?path=perioperative-management-of-patients-receiving-anticoagulants#H2126501\" class=\"medical medical_review\">&quot;Perioperative management of patients receiving anticoagulants&quot;, section on 'Bridging anticoagulation'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For patients receiving <a href=\"topic.htm?path=rivaroxaban-drug-information\" class=\"drug drug_general\">rivaroxaban</a>, <a href=\"topic.htm?path=apixaban-drug-information\" class=\"drug drug_general\">apixaban</a>, or <a href=\"topic.htm?path=edoxaban-drug-information\" class=\"drug drug_general\">edoxaban</a>, the guidelines from multiple societies recommend that the last dose be taken &gt;48 hours before a high-risk endoscopic procedure, and that patients on <a href=\"topic.htm?path=dabigatran-drug-information\" class=\"drug drug_general\">dabigatran</a> receive the last dose &gt;72 hours before the procedure. The timing of reintroduction of anticoagulation also should be individualized [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/38\" class=\"abstract_t\">38</a>]. (See <a href=\"topic.htm?path=management-of-anticoagulants-in-patients-undergoing-endoscopic-procedures\" class=\"medical medical_review\">&quot;Management of anticoagulants in patients undergoing endoscopic procedures&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H16\"><span class=\"h2\">Endoscopic techniques</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The risk of bleeding is increased when sphincterotomy is performed in settings with relatively inexperienced endoscopists or when the endoscopy unit volume is low [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/2,7\" class=\"abstract_t\">2,7</a>]. These observations underscore that technique is of primary importance. Improvement in endoscopic methods may explain the slight decrease in the sphincterotomy-induced bleeding rate observed over time [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/1,20\" class=\"abstract_t\">1,20</a>].</p><p>Bleeding can be prevented or limited by proper orientation of the wire, avoidance of &quot;zipper&quot; cuts and unnecessarily long cuts, and judicious use of the electrocautery current [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/44\" class=\"abstract_t\">44</a>]. Optimal electrocautery settings are uncertain because of a tradeoff in the risk of pancreatitis versus bleeding. Pure-cut electrocautery current is associated with an increase in the frequency of localized bleeding, which may temporarily obscure the view and interfere with the procedure [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/45\" class=\"abstract_t\">45</a>].</p><p>Some endoscopists combine pure-cut and blended current in sequence, starting with pure cut and completing the sphincterotomy with blended current [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/46\" class=\"abstract_t\">46</a>]. However, this approach did not reduce the rate of clinically significant post-sphincterotomy bleeding in two comparative studies [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/47,48\" class=\"abstract_t\">47,48</a>]. (See <a href=\"topic.htm?path=post-endoscopic-retrograde-cholangiopancreatography-ercp-pancreatitis\" class=\"medical medical_review\">&quot;Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis&quot;</a>.)</p><p>Mixed-current settings automatically vary the intensity of current and current blend according to tissue resistance. A randomized trial from Germany found a reduced rate of minor bleeding following sphincterotomy compared with a conventional current generator [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/49\" class=\"abstract_t\">49</a>]. There were no episodes of moderate or severe bleeding. Similar conclusions were reached in a large retrospective study [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/50\" class=\"abstract_t\">50</a>] and in a randomized trial [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/51\" class=\"abstract_t\">51</a>]. Endoscopically observed bleeding occurred less often in the mixed-current group, but there were no significant differences in clinically evident bleeding. (See <a href=\"topic.htm?path=standard-biliary-sphincterotomy-technique-the-cutting-edge\" class=\"medical medical_review\">&quot;Standard biliary sphincterotomy technique: The cutting edge&quot;</a>.)</p><p>A retrospective study compared the rate of post-ERCP bleeding in patients with cirrhosis who underwent sphincterotomy with different electrosurgical current generators in two consecutive periods: a conventional electrosurgical current generator applying blended current used up to 2009, at which time it was replaced by a generator applying mixed current. Bleeding was observed in 3 out of 15 patients in the first period, and none out of 14 patients in the more recent period (p = 0.07) [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/52\" class=\"abstract_t\">52</a>].</p><p>For treatment of small bile duct stones in patients with hemostatic disorders, endoscopic balloon dilation (EBD) can reduce the risk of bleeding compared with standard sphincterotomy. However, EBD has been associated with an increased risk of pancreatitis. (See <a href=\"topic.htm?path=endoscopic-balloon-dilatation-for-removal-of-bile-duct-stones\" class=\"medical medical_review\">&quot;Endoscopic balloon dilatation for removal of bile duct stones&quot;</a>.)</p><p>A technique of combining a small sphincterotomy with balloon dilation may reduce the risk of perforation and bleeding [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/53\" class=\"abstract_t\">53</a>].</p><p>Use of a covered sphincterotome to decrease the risk of bleeding was examined in a prospective study [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/54\" class=\"abstract_t\">54</a>]. The rationale for using such a device is to provide more controlled cutting and to avoid &quot;zipper&quot; cuts. Use of a partially covered sphincterotome was not associated with a lower frequency of post-endoscopic sphincterotomy bleeding compared with an uncovered sphincterotome.</p><p>Submucosal injections have also been studied for the prevention of postsphincterotomy bleeding. In a randomized prospective trial, prophylactic submucosal injection of hypertonic saline-epinephrine seemed to be effective for the prevention of bleeding [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/55\" class=\"abstract_t\">55</a>]. Additional studies are needed to determine if this technique should routinely be employed for patients at increased for bleeding.</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h1\">MANAGEMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Post-sphincterotomy bleeding often stops spontaneously and is rarely life-threatening, except in patients with a bleeding diathesis. Most clinically significant bleeding can be managed with medical treatment and endoscopic therapy, which should be performed without delay in patients who have immediate bleeding [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/1,7\" class=\"abstract_t\">1,7</a>]. Angiography or surgery is usually reserved for patients with refractory bleeding. In one study [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/7\" class=\"abstract_t\">7</a>], surgery was required in only 2 of 48 bleeding patients (0.08 percent of the overall series). In a study involving 1827 patients, two of 21 patients (0.11 percent) with clinically relevant bleeding required surgery [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/2\" class=\"abstract_t\">2</a>]. </p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h2\">Endoscopic therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A number of endoscopic techniques are used to control bleeding, singularly or in combination: injection therapy, mechanical methods, and thermal methods. When performing endoscopic hemostasis of bleeding after biliary sphincterotomy, it is advisable to avoid any trauma to the pancreatic orifice, which is located below the lower &ldquo;rim&rdquo; of the sphincterotomy (<a href=\"image.htm?imageKey=GAST%2F113782\" class=\"graphic graphic_diagnosticimage graphicRef113782 \">image 1</a>). </p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h3\">Injection therapy</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Injection therapy with <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> &ndash; The most used and generally effective endoscopic intervention is injection therapy with diluted epinephrine (1:10,000) through a sclerotherapy needle [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/9,11\" class=\"abstract_t\">9,11</a>]. Injection of sclerosing agents in combination with epinephrine has also been described [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/11,17,22,56-58\" class=\"abstract_t\">11,17,22,56-58</a>], but <strong>extreme caution is required when injecting sclerosants</strong> due to the risk of nonselective inflammatory or necrotic effects, which have been documented when these agents have been used to treat bleeding peptic ulcers [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/59,60\" class=\"abstract_t\">59,60</a>].</p><p/><p class=\"bulletIndent1\">The efficacy of injection therapy was illustrated in a study that included 1304 patients, 10 percent of whom developed bleeding [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/22\" class=\"abstract_t\">22</a>]. Bleeding was initially treated by spraying the area with <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> followed by epinephrine injection if bleeding persisted. Patients with a visible vessel were treated with combination therapy with epinephrine injection and absolute alcohol injection (mean volume 0.3 mL). Initial hemostasis was achieved in all patients. However, rebleeding occurred in eight (all of whom initially had moderate to severe bleeding); bleeding was controlled in all these patients with repeated endoscopic therapy.</p><p/><p class=\"bulletIndent1\">In a retrospective study, <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> injection alone was as effective as epinephrine injection combined with thermotherapy for the management of delayed post-endoscopic sphincterotomy bleeding, but this study had severe limitations. One of the primary limitations is that it is not clear whether the patients were undergoing dual therapy because of epinephrine monotherapy failure [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/61\" class=\"abstract_t\">61</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Injection therapy with fibrin sealant &ndash; The injection of fibrin sealant, a two-component adhesive consisting of human fibrin and thrombin with the addition of coagulation factor XIII, has also been successfully used to stop postsphincterotomy bleeding in the case of rebleeding after injection therapy with <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/62\" class=\"abstract_t\">62</a>]. The injection of a fibrin sealant has potential advantages over sclerosants. (See <a href=\"topic.htm?path=fibrin-sealants\" class=\"medical medical_review\">&quot;Fibrin sealants&quot;</a>.)</p><p/><p class=\"bulletIndent1\">However, a number of drawbacks should be considered: difficulty of preparation and injection, high cost, potential risk of transmission of infection, and possible occlusion of the pancreatic orifice if the injection is not carefully targeted in the upper rim of the sphincterotomy. It is advisable to secure biliary and pancreatic outflow by placing pancreatic and biliary stents [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/63\" class=\"abstract_t\">63</a>].</p><p/><p class=\"headingAnchor\" id=\"H20\"><span class=\"h3\">Mechanical methods</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hemoclip &ndash; When injection therapy with <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> fails or bleeding recurs, hemostasis can be achieved by precise placement of one or more hemoclips at the bleeding site [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/64,65\" class=\"abstract_t\">64,65</a>]. However, clips may be difficult to apply with the side-viewing duodenoscope in the setting of active bleeding. In addition, clips may be inadvertently applied to the pancreatic orifice with the associated risk of pancreatitis. In one series of patients who had uncontrolled endoscopic sphincterotomy-induced hemorrhage, the bleeding was successfully treated by cap-assisted application of hemoclip with a forward-viewing endoscope in 9 of 10 patients, with one patient developing mild pancreatitis after the procedure [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/66\" class=\"abstract_t\">66</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Balloon tamponade &ndash; Balloon tamponade can be achieved with a standard stone extraction balloon catheter [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/7,67\" class=\"abstract_t\">7,67</a>]. The efficacy of this method has not been well studied.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Temporary self-expandable metal stent &ndash; Temporary placement of a fully covered self-expandable metal stent resulted in immediate hemostasis in five patients with post-endoscopic biliary sphincterotomy bleeding [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/68\" class=\"abstract_t\">68</a>]. Two other case series described this endoscopic hemostatic technique [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/69,70\" class=\"abstract_t\">69,70</a>]. This form of mechanical tamponade can be considered in select situations, such as in patients with bleeding not responding to other endoscopic measures. The authors note that this method has a number of drawbacks, and stent migration is the main concern. On the other hand, this technique may be effective for both bleeding originating from the papilla and bleeding due to trauma of the common bile duct [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/70\" class=\"abstract_t\">70</a>]. Metallic stents are generally not used in the pancreatic duct, but in a case report, a covered pancreatic metal stent (6 mm diameter) stopped massive bleeding after endoscopic pancreatic sphincterotomy for removal of a pancreatic stone [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/71\" class=\"abstract_t\">71</a>]. Percutaneous placement of a covered self-expandable stent proved effective in a case of post-ERCP massive delayed bleeding in which endoscopic hemostasis was unachievable [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/72\" class=\"abstract_t\">72</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Endoscopic band ligation &ndash; Successful hemostasis by using endoscopic band ligation was reported in a case of severe post-endoscopic sphincterotomy bleeding uncontrolled by other methods [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/73\" class=\"abstract_t\">73</a>]. However, endoscopic band ligation at the site of bleeding from sphincterotomy is likely to be technically difficult because it requires use of a forward-viewing endoscope. It also requires that plastic biliary stents be inserted prior to banding in order to protect the biliary orifice.</p><p/><p class=\"headingAnchor\" id=\"H21\"><span class=\"h3\">Thermal methods</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Application of electrocautery current is more difficult than injection therapy but can be attempted with the sphincterotome wire [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/6\" class=\"abstract_t\">6</a>] or with an electrocautery [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/74\" class=\"abstract_t\">74</a>] or heater probe [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/75\" class=\"abstract_t\">75</a>] if a visible vessel or a specific bleeding point can be identified [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/31\" class=\"abstract_t\">31</a>]. Argon plasma coagulation is another thermal method that can be used cautiously to achieve permanent hemostasis after injection therapy with <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/76\" class=\"abstract_t\">76</a>].</p><p>An extension of the sphincterotomy has been suggested to allow full retraction of a partially severed vessel in cases when brisk bleeding occurs during the procedure [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/77\" class=\"abstract_t\">77</a>]. However, sphincterotomy should be fully completed only if required for stone removal.</p><p class=\"headingAnchor\" id=\"H82343462\"><span class=\"h3\">Hemostatic nanopowder</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A nanopowder that promotes hemostasis is being studied in prospective trials. (See <a href=\"topic.htm?path=overview-of-the-treatment-of-bleeding-peptic-ulcers\" class=\"medical medical_review\">&quot;Overview of the treatment of bleeding peptic ulcers&quot;</a>.)</p><p>In a case of severe delayed bleeding, post-sphincterotomy hemostasis was achieved through the application of 4 g of the hemostatic agent, with no evidence of secondary biliary obstruction [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/78\" class=\"abstract_t\">78</a>]. The use of hemostatic nanopowder should be considered as a possible alternative to standard endoscopic therapy in cases where the position, site, or size of the bleeding site makes conventional endoscopic therapy difficult. </p><p class=\"headingAnchor\" id=\"H28499033\"><span class=\"h2\">Pharmacologic treatment</span></p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h3\">Recombinant factor VIIa</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=factor-viia-activated-recombinant-human-drug-information\" class=\"drug drug_general\">Recombinant human factor VIIa</a> was effective in stopping bleeding in a patient with a coagulopathy who had delayed bleeding after sphincterotomy [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/79\" class=\"abstract_t\">79</a>]. (See <a href=\"topic.htm?path=endoscopic-procedures-in-patients-with-disorders-of-hemostasis\" class=\"medical medical_review\">&quot;Endoscopic procedures in patients with disorders of hemostasis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H126520251\"><span class=\"h3\">Vasoactive drugs</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infusion of terlipressin in four patients [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/80\" class=\"abstract_t\">80</a>] and infusion of <a href=\"topic.htm?path=nitroglycerin-glyceryl-trinitrate-drug-information\" class=\"drug drug_general\">nitroglycerin</a> in another case report [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/81\" class=\"abstract_t\">81</a>] were effective in controlling hemobilia during therapeutic ERCP in patients with portal biliopathy (intra- and extrahepatic bile duct abnormalities that are a result of portal hypertension).</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h2\">Angiographic treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Celiac or superior mesenteric angiography with transcatheter infusion of vasopressin or embolization of the bleeding artery can be effective but is uncommonly performed as underscored by the paucity of data on this approach [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/9,82\" class=\"abstract_t\">9,82</a>]. It is also worth remembering that arterial embolization is technically difficult and may cause infarction of abdominal organs [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/83\" class=\"abstract_t\">83</a>], although studies have shown a reduction in the risk of bowel infarction due to technical improvements and increased experience of the interventionalists [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/84\" class=\"abstract_t\">84</a>]. </p><p>In one series, over eight years, 12 embolization procedures were performed in 11 patients for management of post-sphincterotomy bleeding not controlled by endoscopy. Technical success was achieved in 11 of 12 procedures, clinical success was achieved in 10 of 11 patients, and 1 patient was referred for surgical intervention due to rebleeding [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/85\" class=\"abstract_t\">85</a>]. (See <a href=\"topic.htm?path=angiographic-control-of-nonvariceal-gastrointestinal-bleeding-in-adults\" class=\"medical medical_review\">&quot;Angiographic control of nonvariceal gastrointestinal bleeding in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H24\"><span class=\"h2\">Surgery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>As mentioned above, the need for surgery has decreased during the past two decades because of success with endoscopic methods [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/1\" class=\"abstract_t\">1</a>]. The most commonly performed operation involves conversion of the sphincterotomy into a sutured sphincteroplasty and oversewing the bleeding artery at the apex of the sphincterotomy. If anatomic changes make direct access to the ampulla through the duodenal wall impossible, a Fogarty catheter can be inserted into the common bile duct (either through the cystic duct or a choledochotomy) permitting balloon tamponade of the bleeding point [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/86\" class=\"abstract_t\">86</a>]. In older series, surgery was associated with postoperative mortality rates as high as 50 percent, largely because many of the patients treated by ERCP were considered to be too ill for surgery [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/87\" class=\"abstract_t\">87</a>].</p><p>The infusion of a topical gelatin matrix-thrombin hemostatic agent into the distal portion of the common bile duct during urgent surgical exploration was effective in a patient with life-threatening bleeding after endoscopic sphincterotomy [<a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/88\" class=\"abstract_t\">88</a>]. Further experience is needed to confirm the efficacy of this topical hemostatic agent in cases of bleeding after ERCP. (See <a href=\"topic.htm?path=overview-of-topical-hemostatic-agents-and-tissues-adhesives\" class=\"medical medical_review\">&quot;Overview of topical hemostatic agents and tissues adhesives&quot;</a>.)</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beyond the Basics topics (see <a href=\"topic.htm?path=ercp-endoscopic-retrograde-cholangiopancreatography-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: ERCP (endoscopic retrograde cholangiopancreatography) (Beyond the Basics)&quot;</a>) </p><p/><p class=\"headingAnchor\" id=\"H70566318\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Clinically significant bleeding is an uncommon complication of diagnostic endoscopic retrograde cholangiopancreatography (ERCP). Bleeding related to ERCP is most often seen following sphincterotomy. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Post-ERCP bleeding can be defined as mild, moderate, or severe based upon a consensus definition. (See <a href=\"#H2\" class=\"local\">'Assessing severity'</a> above.):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Mild: clinical evidence of bleeding (ie, in addition to endoscopic visualization), hemoglobin drop &lt;3 <span class=\"nowrap\">g/dL,</span> and no need for transfusion.</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Moderate: need for transfusion (4 units of packed red blood cells or less), and no angiographic intervention or surgery.</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Severe: transfusion 5 units or more, or intervention (angiographic or surgical).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The overall risk of bleeding in patients undergoing sphincterotomy is approximately 1 to 2 percent. Most bleeding episodes are mild to moderate in severity. (See <a href=\"#H4\" class=\"local\">'Incidence'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The risk of bleeding can be minimized by identifying patients at risk, correcting coagulation abnormalities, and careful technique. (See <a href=\"#H9\" class=\"local\">'Prevention'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Post-sphincterotomy bleeding often stops spontaneously and is rarely life-threatening, except in patients with a bleeding diathesis. Most clinically relevant bleeds can be managed with medical treatment and endoscopic therapy, which should be performed without delay in patients who have immediate bleeding. Angiography or surgery is usually reserved for patients with refractory bleeding. (See <a href=\"#H17\" class=\"local\">'Management'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/1\" class=\"nounderline abstract_t\">Rabenstein T, Schneider HT, Hahn EG, Ell C. 25 years of endoscopic sphincterotomy in Erlangen: assessment of the experience in 3498 patients. Endoscopy 1998; 30:A194.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/2\" class=\"nounderline abstract_t\">Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998; 48:1.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/3\" class=\"nounderline abstract_t\">Lin LF, Siauw CP, Ho KS, Tung JC. ERCP in post-Billroth II gastrectomy patients: emphasis on technique. Am J Gastroenterol 1999; 94:144.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/4\" class=\"nounderline abstract_t\">ASGE Standards of Practice Committee, Acosta RD, Abraham NS, et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc 2016; 83:3.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/5\" class=\"nounderline abstract_t\">Ferreira LE, Baron TH. Post-sphincterotomy bleeding: who, what, when, and how. Am J Gastroenterol 2007; 102:2850.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/6\" class=\"nounderline abstract_t\">Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991; 37:383.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/7\" class=\"nounderline abstract_t\">Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996; 335:909.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/8\" class=\"nounderline abstract_t\">Finnie IA, Tobin MV, Morris AI, Gilmore IT. Late bleeding after endoscopic sphincterotomy for bile duct calculi. BMJ 1991; 302:1144.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/9\" class=\"nounderline abstract_t\">Boujaoud&eacute; J, Pelletier G, Fritsch J, et al. Management of clinically relevant bleeding following endoscopic sphincterotomy. Endoscopy 1994; 26:217.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/10\" class=\"nounderline abstract_t\">Gholson CF, Favrot D, Vickers B, et al. Delayed hemorrhage following endoscopic retrograde sphincterotomy for choledocholithiasis. Dig Dis Sci 1996; 41:831.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/11\" class=\"nounderline abstract_t\">V&aacute;sconez C, Llach J, Bordas JM, et al. Injection treatment of hemorrhage induced by endoscopic sphincterotomy. Endoscopy 1998; 30:37.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/12\" class=\"nounderline abstract_t\">Ferreira LE, Fatima J, Baron TH. Clinically significant delayed postsphincterotomy bleeding: a twelve year single center experience. Minerva Gastroenterol Dietol 2007; 53:215.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/13\" class=\"nounderline abstract_t\">Freeman ML, Nelson DB, Sherman S, et al. Same-day discharge after endoscopic biliary sphincterotomy: observations from a prospective multicenter complication study. The Multicenter Endoscopic Sphincterotomy (MESH) Study Group. Gastrointest Endosc 1999; 49:580.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/14\" class=\"nounderline abstract_t\">Ho KY, Montes H, Sossenheimer MJ, et al. Features that may predict hospital admission following outpatient therapeutic ERCP. Gastrointest Endosc 1999; 49:587.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/15\" class=\"nounderline abstract_t\">Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001; 96:417.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/16\" class=\"nounderline abstract_t\">Vandervoort J, Soetikno RM, Tham TC, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 2002; 56:652.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/17\" class=\"nounderline abstract_t\">Christensen M, Matzen P, Schulze S, Rosenberg J. Complications of ERCP: a prospective study. Gastrointest Endosc 2004; 60:721.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/18\" class=\"nounderline abstract_t\">Williams EJ, Taylor S, Fairclough P, et al. Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy 2007; 39:793.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/19\" class=\"nounderline abstract_t\">Wang P, Li ZS, Liu F, et al. Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol 2009; 104:31.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/20\" class=\"nounderline abstract_t\">Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007; 102:1781.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/21\" class=\"nounderline abstract_t\">Nelson DB, Freeman ML. Major hemorrhage from endoscopic sphincterotomy: risk factor analysis. J Clin Gastroenterol 1994; 19:283.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/22\" class=\"nounderline abstract_t\">Kim HJ, Kim MH, Kim DI, et al. Endoscopic hemostasis in sphincterotomy-induced hemorrhage: its efficacy and safety. Endoscopy 1999; 31:431.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/23\" class=\"nounderline abstract_t\">Wilcox CM, Canakis J, M&ouml;nkem&uuml;ller KE, et al. Patterns of bleeding after endoscopic sphincterotomy, the subsequent risk of bleeding, and the role of epinephrine injection. Am J Gastroenterol 2004; 99:244.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/24\" class=\"nounderline abstract_t\">Inamdar S, Berzin TM, Berkowitz J, et al. Decompensated cirrhosis may be a risk factor for adverse events in endoscopic retrograde cholangiopancreatography. Liver Int 2016; 36:1457.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/25\" class=\"nounderline abstract_t\">Hori Y, Naitoh I, Nakazawa T, et al. Feasibility of endoscopic retrograde cholangiopancreatography-related procedures in hemodialysis patients. J Gastroenterol Hepatol 2014; 29:648.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/26\" class=\"nounderline abstract_t\">Margulies C, Siqueira ES, Silverman WB, et al. The effect of endoscopic sphincterotomy on acute and chronic complications of biliary endoprostheses. Gastrointest Endosc 1999; 49:716.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/27\" class=\"nounderline abstract_t\">Leung JW, Chan FK, Sung JJ, Chung S. Endoscopic sphincterotomy-induced hemorrhage: a study of risk factors and the role of epinephrine injection. Gastrointest Endosc 1995; 42:550.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/28\" class=\"nounderline abstract_t\">Williams EJ, Green J, Beckingham I, et al. Guidelines on the management of common bile duct stones (CBDS). Gut 2008; 57:1004.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/29\" class=\"nounderline abstract_t\">Prat F, Tennenbaum R, Ponsot P, et al. Endoscopic sphincterotomy in patients with liver cirrhosis. Gastrointest Endosc 1996; 43:127.</a></li><li class=\"breakAll\">Henning H, Lightdale CJ, Look D. Contraindications &ndash; Coagulation disorders. In: Color Atlas of diagnostic Laparoscopy, Stuttgart, Thieme, New York 1994. p.17.</li><li class=\"breakAll\">Sherlock S, Dooley J. Needle biopsy of the liver. In: Diseases of the Liver and Biliary System, 9th edition, Blackwell, Oxford 1993. p.33.</li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/32\" class=\"nounderline abstract_t\">Sherman S, Hawes RH, Nisi R, Lehman GA. Endoscopic sphincterotomy-induced hemorrhage: treatment with multipolar electrocoagulation. Gastrointest Endosc 1992; 38:123.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/33\" class=\"nounderline abstract_t\">ASGE Standards of Practice Committee, Pasha SF, Acosta R, et al. Routine laboratory testing before endoscopic procedures. Gastrointest Endosc 2014; 80:28.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/34\" class=\"nounderline abstract_t\">Egan RJ, Nicholls J, Walker S, et al. Routine coagulation screening is an unnecessary step prior to ERCP in patients without biochemical evidence of jaundice: a cross-centre study. Int J Surg 2014; 12:1216.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/35\" class=\"nounderline abstract_t\">Bickerstaff KI, Berry AR, Chapman RW, Britton BJ. Endoscopic sphincterotomy for the palliation of ampullary carcinoma. Br J Surg 1990; 77:160.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/36\" class=\"nounderline abstract_t\">Kimchi NA, Broide E, Scapa E, Birkenfeld S. Antiplatelet therapy and the risk of bleeding induced by gastrointestinal endoscopic procedures. A systematic review of the literature and recommendations. Digestion 2007; 75:36.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/37\" class=\"nounderline abstract_t\">Hussain N, Alsulaiman R, Burtin P, et al. The safety of endoscopic sphincterotomy in patients receiving antiplatelet agents: a case-control study. Aliment Pharmacol Ther 2007; 25:579.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/38\" class=\"nounderline abstract_t\">Baron TH, Kamath PS, McBane RD. New anticoagulant and antiplatelet agents: a primer for the gastroenterologist. Clin Gastroenterol Hepatol 2014; 12:187.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/39\" class=\"nounderline abstract_t\">Ono S, Fujishiro M, Yoshida N, et al. Thienopyridine derivatives as risk factors for bleeding following high risk endoscopic treatments: Safe Treatment on Antiplatelets (STRAP) study. Endoscopy 2015; 47:632.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/40\" class=\"nounderline abstract_t\">Bousti&egrave;re C, Veitch A, Vanbiervliet G, et al. Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2011; 43:445.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/41\" class=\"nounderline abstract_t\">Veitch AM, Vanbiervliet G, Gershlick AH, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Gut 2016; 65:374.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/42\" class=\"nounderline abstract_t\">Lee MG, Kim J, Lee SH, et al. Effect of sustained use of platelet aggregation inhibitors on post-endoscopic sphincterotomy bleeding. Dig Endosc 2014; 26:737.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/43\" class=\"nounderline abstract_t\">Hamada T, Yasunaga H, Nakai Y, et al. Bleeding after endoscopic sphincterotomy or papillary balloon dilation among users of antithrombotic agents. Endoscopy 2015; 47:997.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/44\" class=\"nounderline abstract_t\">Ratani RS, Mills TN, Ainley CC, Swain CP. Electrophysical factors influencing endoscopic sphincterotomy. Gastrointest Endosc 1999; 49:43.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/45\" class=\"nounderline abstract_t\">Verma D, Kapadia A, Adler DG. Pure versus mixed electrosurgical current for endoscopic biliary sphincterotomy: a meta-analysis of adverse outcomes. Gastrointest Endosc 2007; 66:283.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/46\" class=\"nounderline abstract_t\">Pasricha P. Current news about sphincterotomy-induced pancreatitis: does electrocautery setting make a difference? Gastroenterology 1998; 115:1024.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/47\" class=\"nounderline abstract_t\">Gorelick A, Cannon M, Barnett J, et al. First cut, then blend: an electrocautery technique affecting bleeding at sphincterotomy. Endoscopy 2001; 33:976.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/48\" class=\"nounderline abstract_t\">Stefanidis G, Karamanolis G, Viazis N, et al. A comparative study of postendoscopic sphincterotomy complications with various types of electrosurgical current in patients with choledocholithiasis. Gastrointest Endosc 2003; 57:192.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/49\" class=\"nounderline abstract_t\">Kohler A, Maier M, Benz C, et al. A new HF current generator with automatically controlled system (Endocut mode) for endoscopic sphincterotomy--preliminary experience. Endoscopy 1998; 30:351.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/50\" class=\"nounderline abstract_t\">Perini RF, Sadurski R, Cotton PB, et al. Post-sphincterotomy bleeding after the introduction of microprocessor-controlled electrosurgery: does the new technology make the difference? Gastrointest Endosc 2005; 61:53.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/51\" class=\"nounderline abstract_t\">Norton ID, Petersen BT, Bosco J, et al. A randomized trial of endoscopic biliary sphincterotomy using pure-cut versus combined cut and coagulation waveforms. Clin Gastroenterol Hepatol 2005; 3:1029.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/52\" class=\"nounderline abstract_t\">Parlak E, K&ouml;ksal A&#350;, &Ouml;zta&#351; E, et al. Is there a safer electrosurgical current for endoscopic sphincterotomy in patients with liver cirrhosis? Wien Klin Wochenschr 2016; 128:573.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/53\" class=\"nounderline abstract_t\">Attasaranya S, Cheon YK, Vittal H, et al. Large-diameter biliary orifice balloon dilation to aid in endoscopic bile duct stone removal: a multicenter series. Gastrointest Endosc 2008; 67:1046.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/54\" class=\"nounderline abstract_t\">Katsinelos P, Paroutoglou G, Kountouras J, et al. Partially covered vs uncovered sphincterotome and post-endoscopic sphincterotomy bleeding. World J Gastroenterol 2010; 16:5077.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/55\" class=\"nounderline abstract_t\">Matsushita M, Takakuwa H, Shimeno N, et al. Prophylactic injection of hypertonic saline-epinephrine oral to the papilla for prevention of postsphincterotomy bleeding. J Clin Gastroenterol 2010; 44:e167.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/56\" class=\"nounderline abstract_t\">Grimm H, Soehendra N. [Infiltrating injection in the management of post-papillotomy hemorrhages]. Dtsch Med Wochenschr 1983; 108:1512.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/57\" class=\"nounderline abstract_t\">Costamagna G. What to do when the papilla bleeds after endoscopic sphincterotomy. Endoscopy 1998; 30:40.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/58\" class=\"nounderline abstract_t\">Park DH, Kim MH, Lee SK, et al. Endoscopic sphincterotomy vs. endoscopic papillary balloon dilation for choledocholithiasis in patients with liver cirrhosis and coagulopathy. Gastrointest Endosc 2004; 60:180.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/59\" class=\"nounderline abstract_t\">Loperfido S, Patelli G, La Torre L. Extensive necrosis of gastric mucosa following injection therapy of bleeding peptic ulcer. Endoscopy 1990; 22:285.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/60\" class=\"nounderline abstract_t\">Chester JF, Hurley PR. Gastric necrosis: a complication of endoscopic sclerosis for bleeding peptic ulcer. Endoscopy 1990; 22:287.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/61\" class=\"nounderline abstract_t\">Tsou YK, Lin CH, Liu NJ, et al. Treating delayed endoscopic sphincterotomy-induced bleeding: epinephrine injection with or without thermotherapy. World J Gastroenterol 2009; 15:4823.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/62\" class=\"nounderline abstract_t\">Born P, Ott R, R&ouml;sch T. Endoscopic hemostasis using fibrin sealant for postsphincterotomy bleeding: report of two cases. Gastrointest Endosc 2000; 51:731.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/63\" class=\"nounderline abstract_t\">Mutignani M, Seerden T, Tringali A, et al. Endoscopic hemostasis with fibrin glue for refractory postsphincterotomy and postpapillectomy bleeding. Gastrointest Endosc 2010; 71:856.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/64\" class=\"nounderline abstract_t\">Baron TH, Norton ID, Herman L. Endoscopic hemoclip placement for post-sphincterotomy bleeding. Gastrointest Endosc 2000; 52:662.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/65\" class=\"nounderline abstract_t\">Katsinelos P, Paroutoglou G, Beltsis A, et al. Endoscopic hemoclip placement for postsphincterotomy bleeding refractory to injection therapy: report of two cases. Surg Laparosc Endosc Percutan Tech 2005; 15:238.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/66\" class=\"nounderline abstract_t\">Liu F, Wang GY, Li ZS. Cap-assisted hemoclip application with forward-viewing endoscope for hemorrhage induced by endoscopic sphincterotomy: a prospective case series study. BMC Gastroenterol 2015; 15:135.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/67\" class=\"nounderline abstract_t\">Mosca S, Galasso G. Immediate and late bleeding after endoscopic sphincterotomy. Endoscopy 1999; 31:278.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/68\" class=\"nounderline abstract_t\">Shah JN, Marson F, Binmoeller KF. Temporary self-expandable metal stent placement for treatment of post-sphincterotomy bleeding. Gastrointest Endosc 2010; 72:1274.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/69\" class=\"nounderline abstract_t\">Itoi T, Yasuda I, Doi S, et al. Endoscopic hemostasis using covered metallic stent placement for uncontrolled post-endoscopic sphincterotomy bleeding. Endoscopy 2011; 43:369.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/70\" class=\"nounderline abstract_t\">Valats JC, Funakoshi N, Bauret P, et al. Covered self-expandable biliary stents for the treatment of bleeding after ERCP. Gastrointest Endosc 2013; 78:183.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/71\" class=\"nounderline abstract_t\">Ogura T, Masuda D, Takeuchi T, et al. Novel covered pancreatic metal stents for the treatment of bleeding after endoscopic pancreatic sphincterotomy. Gastrointest Endosc 2016; 83:1293.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/72\" class=\"nounderline abstract_t\">Odemis B, Shorbagi A, Yurdakul M, et al. Percutaneous placement of a biliary self-expandable metallic stent for severe post-ERCP bleeding. Gastrointest Endosc 2014; 80:187.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/73\" class=\"nounderline abstract_t\">Kang MH, Jeong JW, Han JH. Successful hemostasis by using endoscopic band ligation for uncontrolled postendoscopic sphincterotomy bleeding. Gastrointest Endosc 2014; 79:336.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/74\" class=\"nounderline abstract_t\">Katsinelos P, Kountouras J, Chatzimavroudis G, et al. Endoscopic hemostasis using monopolar coagulation for postendoscopic sphincterotomy bleeding refractory to injection treatment. Surg Laparosc Endosc Percutan Tech 2010; 20:84.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/75\" class=\"nounderline abstract_t\">Kuran S, Parlak E, Oguz D, et al. Endoscopic sphincterotomy-induced hemorrhage: treatment with heat probe. Gastrointest Endosc 2006; 63:506.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/76\" class=\"nounderline abstract_t\">Waye JD, Goh KL, Huibregtse K, et al. Endoscopic sphincterotomy: 2002. Gastrointest Endosc 2002; 55:139.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/77\" class=\"nounderline abstract_t\">Leese T, Neoptolemos JP, Carr-Locke DL. Successes, failures, early complications and their management following endoscopic sphincterotomy: results in 394 consecutive patients from a single centre. Br J Surg 1985; 72:215.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/78\" class=\"nounderline abstract_t\">Appleby VJ, Hutchinson JM, Beckett CJ, Moreea S. Use of the haemostatic agent TC-325 in the treatment of bleeding secondary to endoscopic retrograde cholangiopancreatography sphincterotomy. QJM 2015; 108:79.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/79\" class=\"nounderline abstract_t\">Romero-Castro R, Jim&eacute;nez-S&aacute;enz M, Pellicer-Bautista F, Herrer&iacute;as-Guti&eacute;rrez JM. Refractory bleeding after endoscopic sphincterotomy: a new indication for recombinant factor VII therapy? Am J Gastroenterol 2004; 99:2063.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/80\" class=\"nounderline abstract_t\">Tyagi P, Sachdeva S, Agarwal AK, Puri AS. Terlipressin in control of acute hemobilia during therapeutic ERCP in patient with portal biliopathy. Surg Laparosc Endosc Percutan Tech 2009; 19:e198.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/81\" class=\"nounderline abstract_t\">Sharma M, Babu CS, Dhiman RK, Chawla Y. Induced hypotension in the management of acute hemobilia during therapeutic ERCP in a patient with portal biliopathy (with videos). Gastrointest Endosc 2010; 72:1317.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/82\" class=\"nounderline abstract_t\">Saeed M, Kadir S, Kaufman SL, et al. Bleeding following endoscopic sphincterotomy: angiographic management by transcatheter embolization. Gastrointest Endosc 1989; 35:300.</a></li><li class=\"breakAll\">Walker TG, Waltman AC. Angiographic diagnosis and therapy of upper gastrointestinal hemorrhage. In: Therapeutic Endoscopy and Radiology of the Gut, Bennet JR, Hunt RH (Eds), Williams and Wilkins, Baltimore 1990. p.167.</li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/84\" class=\"nounderline abstract_t\">So YH, Choi YH, Chung JW, et al. Selective embolization for post-endoscopic sphincterotomy bleeding: technical aspects and clinical efficacy. Korean J Radiol 2012; 13:73.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/85\" class=\"nounderline abstract_t\">Dunne R, McCarthy E, Joyce E, et al. Post-endoscopic biliary sphincterotomy bleeding: an interventional radiology approach. Acta Radiol 2013; 54:1159.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/86\" class=\"nounderline abstract_t\">Bardaxoglou E, Campion JP, Maddern G, et al. A simple method to control intractable bleeding after endoscopic sphincterotomy. Am J Surg 1994; 167:277.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/87\" class=\"nounderline abstract_t\">Goodall RJ. Bleeding after endoscopic sphincterotomy. Ann R Coll Surg Engl 1985; 67:87.</a></li><li><a href=\"https://www.uptodate.com/contents/post-endoscopic-retrograde-cholangiopancreatography-ercp-bleeding/abstract/88\" class=\"nounderline abstract_t\">Dimitroulis D, Antoniou E, Karidis NP, et al. Surgical control of life-threatening post-ERCP bleeding with a gelatin matrix-thrombin hemostatic agent. Int J Surg Case Rep 2012; 3:471.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 636 Version 21.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H70566318\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">ASSESSING SEVERITY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">TIMING</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">INCIDENCE</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">RISK FACTORS</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">PREVENTION</a><ul><li><a href=\"#H10\" id=\"outline-link-H10\">Prothrombin time and platelet count</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Identifying patients at risk</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Optimizing coagulation abnormalities</a><ul><li><a href=\"#H13\" id=\"outline-link-H13\">- Correction of clotting defects</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">- Antiplatelet drugs</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">- Anticoagulants</a></li></ul></li><li><a href=\"#H16\" id=\"outline-link-H16\">Endoscopic techniques</a></li></ul></li><li><a href=\"#H17\" id=\"outline-link-H17\">MANAGEMENT</a><ul><li><a href=\"#H18\" id=\"outline-link-H18\">Endoscopic therapy</a><ul><li><a href=\"#H19\" id=\"outline-link-H19\">- Injection therapy</a></li><li><a href=\"#H20\" id=\"outline-link-H20\">- Mechanical methods</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">- Thermal methods</a></li><li><a href=\"#H82343462\" id=\"outline-link-H82343462\">- Hemostatic nanopowder</a></li></ul></li><li><a href=\"#H28499033\" id=\"outline-link-H28499033\">Pharmacologic treatment</a><ul><li><a href=\"#H22\" id=\"outline-link-H22\">- Recombinant factor VIIa</a></li><li><a href=\"#H126520251\" id=\"outline-link-H126520251\">- Vasoactive drugs</a></li></ul></li><li><a href=\"#H23\" id=\"outline-link-H23\">Angiographic treatment</a></li><li><a href=\"#H24\" id=\"outline-link-H24\">Surgery</a></li></ul></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H82862213\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H70566318\" id=\"outline-link-H70566318\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"GAST/636|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/113782\" class=\"graphic graphic_diagnosticimage\">- Endoscopic view of biliary sphincterotomy</a></li></ul></li><li><div id=\"GAST/636|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/78401\" class=\"graphic graphic_table\">- Child-Pugh classification</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=ampullary-adenomas-management\" class=\"medical medical_review\">Ampullary adenomas: Management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=angiographic-control-of-nonvariceal-gastrointestinal-bleeding-in-adults\" class=\"medical medical_review\">Angiographic control of nonvariceal gastrointestinal bleeding in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=endoscopic-balloon-dilatation-for-removal-of-bile-duct-stones\" class=\"medical medical_review\">Endoscopic balloon dilatation for removal of bile duct stones</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=endoscopic-procedures-in-patients-with-disorders-of-hemostasis\" class=\"medical medical_review\">Endoscopic procedures in patients with disorders of hemostasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=endoscopic-retrograde-cholangiopancreatography-ercp-after-billroth-ii-reconstruction\" class=\"medical medical_review\">Endoscopic retrograde cholangiopancreatography (ERCP) after Billroth II reconstruction</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=endoscopic-retrograde-cholangiopancreatography-indications-patient-preparation-and-complications\" class=\"medical medical_review\">Endoscopic retrograde cholangiopancreatography: Indications, patient preparation, and complications</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=fibrin-sealants\" class=\"medical medical_review\">Fibrin sealants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-anticoagulants-in-patients-undergoing-endoscopic-procedures\" class=\"medical medical_review\">Management of anticoagulants in patients undergoing endoscopic procedures</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-antiplatelet-agents-in-patients-undergoing-endoscopic-procedures\" class=\"medical medical_review\">Management of antiplatelet agents in patients undergoing endoscopic procedures</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-treatment-of-bleeding-peptic-ulcers\" class=\"medical medical_review\">Overview of the treatment of bleeding peptic ulcers</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-topical-hemostatic-agents-and-tissues-adhesives\" class=\"medical medical_review\">Overview of topical hemostatic agents and tissues adhesives</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ercp-endoscopic-retrograde-cholangiopancreatography-beyond-the-basics\" class=\"medical medical_patient\">Patient education: ERCP (endoscopic retrograde cholangiopancreatography) (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=perioperative-management-of-patients-receiving-anticoagulants\" class=\"medical medical_review\">Perioperative management of patients receiving anticoagulants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=platelet-dysfunction-in-uremia\" class=\"medical medical_review\">Platelet dysfunction in uremia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=post-endoscopic-retrograde-cholangiopancreatography-ercp-pancreatitis\" class=\"medical medical_review\">Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=rare-complications-of-endoscopic-retrograde-cholangiopancreatography-ercp\" class=\"medical medical_review\">Rare complications of endoscopic retrograde cholangiopancreatography (ERCP)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=standard-biliary-sphincterotomy-technique-the-cutting-edge\" class=\"medical medical_review\">Standard biliary sphincterotomy technique: The cutting edge</a></li></ul></div></div>","javascript":null}